OPEN LABEL

Clinical trials for OPEN LABEL explained in plain language.

Never miss a new study

Get alerted when new OPEN LABEL trials appear

Sign up with your email to follow new studies for OPEN LABEL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2

New vaginal capsule aims to tackle stubborn bacterial vaginosis

Disease control Not yet recruiting

This study tests a new drug called GenSci142, given as a vaginal capsule, for treating bacterial vaginosis (BV). About 30 women with BV will receive either GenSci142 or a standard antibiotic cream to compare safety and how well each works. The goal is to see if the new capsule is…

Matched conditions: OPEN LABEL

Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

OPEN LABEL

Get alerted when new OPEN LABEL trials appear

New vaginal capsule aims to tackle stubborn bacterial vaginosis